Arterial hypertension and thyroid function compensation: pharmacotherapy aspects
Based on literature data on arterial hypertension (AH) therapy in hypothyrosis patients, a need for investigating this issue considering pathogenesis of hypothyrosis-specific hemodynamic changes, is emphasized. The author presents original data on differential AH treatment, including АСГ inhibitor p...
Saved in:
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«SILICEA-POLIGRAF» LLC
2008-06-01
|
| Series: | Кардиоваскулярная терапия и профилактика |
| Subjects: | |
| Online Access: | https://cardiovascular.elpub.ru/jour/article/view/1543 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849250749011197952 |
|---|---|
| author | G. B. Selivanova |
| author_facet | G. B. Selivanova |
| author_sort | G. B. Selivanova |
| collection | DOAJ |
| description | Based on literature data on arterial hypertension (AH) therapy in hypothyrosis patients, a need for investigating this issue considering pathogenesis of hypothyrosis-specific hemodynamic changes, is emphasized. The author presents original data on differential AH treatment, including АСГ inhibitor perindopril, in hypothyrosis patients. In this clinical group, perindopril as monotherapy or as a part of combined antihypertensive treatment, was effective in 83,3% of the patients. Therefore, perindopril could be used for pathogenetic AH therapy in hypothyrosis. |
| format | Article |
| id | doaj-art-3dc1074b99b040ed88b2588bfdd20ea0 |
| institution | Kabale University |
| issn | 1728-8800 2619-0125 |
| language | Russian |
| publishDate | 2008-06-01 |
| publisher | «SILICEA-POLIGRAF» LLC |
| record_format | Article |
| series | Кардиоваскулярная терапия и профилактика |
| spelling | doaj-art-3dc1074b99b040ed88b2588bfdd20ea02025-08-20T03:57:09Zrus«SILICEA-POLIGRAF» LLCКардиоваскулярная терапия и профилактика1728-88002619-01252008-06-01731111171261Arterial hypertension and thyroid function compensation: pharmacotherapy aspectsG. B. Selivanova0Russian State Medical University. MoscowBased on literature data on arterial hypertension (AH) therapy in hypothyrosis patients, a need for investigating this issue considering pathogenesis of hypothyrosis-specific hemodynamic changes, is emphasized. The author presents original data on differential AH treatment, including АСГ inhibitor perindopril, in hypothyrosis patients. In this clinical group, perindopril as monotherapy or as a part of combined antihypertensive treatment, was effective in 83,3% of the patients. Therefore, perindopril could be used for pathogenetic AH therapy in hypothyrosis.https://cardiovascular.elpub.ru/jour/article/view/1543arterial hypertensionhypothyrosisprestarium |
| spellingShingle | G. B. Selivanova Arterial hypertension and thyroid function compensation: pharmacotherapy aspects Кардиоваскулярная терапия и профилактика arterial hypertension hypothyrosis prestarium |
| title | Arterial hypertension and thyroid function compensation: pharmacotherapy aspects |
| title_full | Arterial hypertension and thyroid function compensation: pharmacotherapy aspects |
| title_fullStr | Arterial hypertension and thyroid function compensation: pharmacotherapy aspects |
| title_full_unstemmed | Arterial hypertension and thyroid function compensation: pharmacotherapy aspects |
| title_short | Arterial hypertension and thyroid function compensation: pharmacotherapy aspects |
| title_sort | arterial hypertension and thyroid function compensation pharmacotherapy aspects |
| topic | arterial hypertension hypothyrosis prestarium |
| url | https://cardiovascular.elpub.ru/jour/article/view/1543 |
| work_keys_str_mv | AT gbselivanova arterialhypertensionandthyroidfunctioncompensationpharmacotherapyaspects |